Decitabine-Intensified Modified Busulfan/Cyclophosphamide Conditioning Regimen Improves Survival in Acute Myeloid Leukemia Patients Undergoing Related Donor Hematopoietic Stem Cell Transplantation: A Propensity Score Matched Analysis

To identify the benefit of decitabine (Dec)-intensified myeloablative conditioning on the outcomes of patients with acute myeloid leukemia (AML) after related donor hematopoietic stem cell transplantation (HSCT), we performed a retrospective matched‐pair study from a pool of 156 patients to evaluate...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Ziying, Shi, Wei, Lu, Xuan, Lu, Hui, Cao, Xiena, Tang, Liang, Yan, Han, Zhong, Zhaodong, You, Yong, Xia, Linghui, Hu, Yu, Wang, Huafang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8966032/
https://www.ncbi.nlm.nih.gov/pubmed/35371981
http://dx.doi.org/10.3389/fonc.2022.844937

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8966032/
https://www.ncbi.nlm.nih.gov/pubmed/35371981
http://dx.doi.org/10.3389/fonc.2022.844937

Ejemplares similares